The frequency of AKR7A3 promoter hypermethylation with AKR7A3 down-regulation was significantly higher (16/21, 76%) than that in HCC cases without down-regulation (*P = 0.011) (Table 2). Here, AKR7A3 is linked to hepatocellular carcinoma.